Abstract 3315: Preclinical studies of TSN1611, a potent, selective, and orally bioavailable KRASG12D inhibitor
用户sar7Gc5emZOY
12天前
44
10
已关闭
DOI: 10.1158/1538-7445.am2024-3315
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Erchang Shang; Boyu Zhong; Tony Zhang; Chunlan Dong; Shengtang Ma; Anjiang Yang; Ziyang Jia; Renjuan Zheng; Jing Li; Han Fu; Liangbao Lai
全文下载地址: https://aacrjournals.org/cancerres/article/84/6_Supplement/3315/739112/Abstract-3315-Preclinical-studies-of-TSN1611-a

